AU3326000A - Means of early examination of malignant tumor - Google Patents

Means of early examination of malignant tumor

Info

Publication number
AU3326000A
AU3326000A AU33260/00A AU3326000A AU3326000A AU 3326000 A AU3326000 A AU 3326000A AU 33260/00 A AU33260/00 A AU 33260/00A AU 3326000 A AU3326000 A AU 3326000A AU 3326000 A AU3326000 A AU 3326000A
Authority
AU
Australia
Prior art keywords
malignant tumor
early examination
examination
early
malignant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33260/00A
Inventor
George Hosokawa
Katsuaki Uno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immuni-X Inc
UNO AKITANE
Original Assignee
AKITANE UNO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AKITANE UNO filed Critical AKITANE UNO
Publication of AU3326000A publication Critical patent/AU3326000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU33260/00A 1999-03-26 2000-03-23 Means of early examination of malignant tumor Abandoned AU3326000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP11/84230 1999-03-26
JP8423099 1999-03-26
JP23267799 1999-08-19
JP11/232677 1999-08-19
PCT/JP2000/001775 WO2000058728A1 (en) 1999-03-26 2000-03-23 Means of early examination of malignant tumor

Publications (1)

Publication Number Publication Date
AU3326000A true AU3326000A (en) 2000-10-16

Family

ID=26425294

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33260/00A Abandoned AU3326000A (en) 1999-03-26 2000-03-23 Means of early examination of malignant tumor

Country Status (2)

Country Link
AU (1) AU3326000A (en)
WO (1) WO2000058728A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
CA2463049A1 (en) * 2001-10-09 2003-04-17 Akikuni Yagita Novel method of assaying immune activity
JP5236856B2 (en) * 2001-11-09 2013-07-17 ライフ テクノロジーズ コーポレーション Identification, observation and treatment of diseases and identification of biological states using gene expression profiles
US9347945B2 (en) 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
CA2821426A1 (en) * 2005-12-22 2007-07-05 Abbott Laboratories Methods and marker combinations for screening for predisposition to lung cancer
JP6100867B1 (en) * 2015-11-06 2017-03-22 振武 曽 Test methods for analysis of immune status

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6358258A (en) * 1986-08-29 1988-03-14 Nippon Koutai Kenkyusho:Kk Method for testing cytotoxicity
EP0443036B1 (en) * 1989-09-08 1995-09-13 YAMAUCHI, Tamio Method of determining kinetics of immunity
CA2121096A1 (en) * 1993-04-22 1994-10-23 Weng Tao Monoclonal antibodies to bovine cytokines
JP3519832B2 (en) * 1995-09-18 2004-04-19 積水化学工業株式会社 Biological reaction test method
JPH10306029A (en) * 1997-03-07 1998-11-17 Akira Hayashi Cancer immunotherapeutic agent with bacterial cell component as active ingredient

Also Published As

Publication number Publication date
WO2000058728A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
AU7994200A (en) Compositions and methods for therapy and diagnosis of prostate cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2010699A (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
AU3617600A (en) Human breast and ovarian cancer associated gene sequences and polypeptides
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU1939200A (en) Electrochemical treatment of malignant tumors
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU3105700A (en) Methods for detection of antiestrogen-resistant breast cancer
AU2387900A (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
EP1176964B8 (en) Uses of et743 for treating cancer
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU5005697A (en) Methods of preventing breast cancer
AU2608201A (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
HUP0200991A2 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
AU6583700A (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU7817500A (en) Method of tumor imaging
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU3177500A (en) Proteins for diagnosis and treatment of breast cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase